🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 25 mg Ontamalimab

    Takeda

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  2. 9vHPV Vaccine

    Takeda

    Dengue Fever

    phase 3 mab completed

    1 trial

  3. A phase 3, prospective, open-label, multisite, extension of phase 3 studies to assess the long-term safety and tolerability of soticlestat as adjunctive therapy in subjects with Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)

    Takeda

    Dravet and Lennox-Gastaut Syndromes

    phase 3 other active

    1 trial

  4. ADVATE 500 IU powder and solvent for solution for injection., VEYVONDI 1300 IU powder and solvent for solution for injection., ADVATE 1000 IU powder and solvent for solution for injection., VEYVONDI 650 IU powder and solvent for solution for injection.

    Takeda

    severe von Willebrand Disease

    phase 3 small molecule active

    1 trial

  5. ALX1-11

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  6. ALX1-11 (drug)

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  7. AMG 479

    Takeda

    Adenocarcinoma of the Pancreas

    phase 3 small molecule completed

    1 trial

  8. AMG 706

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  9. ARALAST NP 60 mg/kg

    Takeda

    Chronic Obstructive Pulmonary Disease

    phase 3 mab terminated

    1 trial

  10. ASCs (Cx401, company code)

    Takeda

    Anal Fistula

    phase 3 small molecule completed

    1 trial

  11. Actovegin

    Takeda

    Peripheral Arterial Diseases

    phase 3 small molecule completed

    1 trial

  12. Actovegin

    Takeda

    Post-Stroke Cognitive Impairment (PSCI)

    phase 3 small molecule completed

    1 trial

  13. Adynovate

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  14. Alisertib

    Takeda

    Relapsed Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  15. Alogliptin

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    5 trials

  16. Alogliptin

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    9 trials

  17. Alogliptin Benzoate

    Takeda

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  18. Alogliptin and glimepiride

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  19. Alogliptin and glyburide

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  20. Alogliptin and insulin

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  21. Alogliptin and metformin

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  22. Alogliptin and metformin

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  23. Alogliptin and pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  24. Alogliptin and pioglitazone

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  25. Alogliptin and voglibose

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  26. Amlodipine

    Takeda

    Hypertension

    phase 3 small molecule terminated

    1 trial

  27. Anagrelide Hydrochloride

    Takeda

    Essential Thrombocythemia (ET)

    phase 3 small molecule completed

    1 trial

  28. Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    3 trials

  29. Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)

    Takeda

    Hemophilia A

    phase 3 mab terminated

    1 trial

  30. Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)

    Takeda

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  31. Azacitidine

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  32. Azilsartan

    Takeda

    Pediatric Hypertension

    phase 3 small molecule completed

    2 trials

  33. Azilsartan Medoxomil

    Takeda

    Hypertension

    phase 3 small molecule completed

    7 trials

  34. Azilsartan Medoxomil and amlodipine

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  35. Azilsartan medoxomil and chlorthalidone

    Takeda

    Safety

    phase 3 small molecule completed

    1 trial

  36. Azilsartan medoxomil and chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    2 trials

  37. Azilsartan medoxomil and chlorthalidone

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    4 trials

  38. Azilsartan medoxomil and olmesartan

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  39. Azilsartan medoxomil with or without add-on chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  40. Azilsartan medoxomil/placebo

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  41. BAX 326

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

  42. BAX 326 (Recombinant factor IX)

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

  43. BAX326

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

  44. BAX855

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  45. Brentuximab Vedotin

    Takeda

    Primary Cutaneous Anaplastic Large Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  46. Brentuximab vedotin

    Takeda

    Diffuse Large B-cell-lymphoma

    phase 3 small molecule active

    1 trial

  47. Brigatinib

    Takeda

    ALK+ Advanced NSCLC

    phase 3 small molecule completed

    1 trial

  48. Budesonide oral suspension

    Takeda

    Eosinophilic Esophagitis (EoE)

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.